Skip to content

pixlbio vs REPROCELL

pixlbio logo

pixlbio

pixl x bio: from cells to pixels to predictions

21 employees · est. 2025 · Uppsala, Sweden

VS
REPROCELL logo

REPROCELL

Better Translating Discoveries into Therapies

58 employees · est. 2003 · Yokohama, Japan

REPROCELL is the older company (2025 vs 2003); REPROCELL is the larger of the two.

Side-by-Side Comparison

pixlbio REPROCELL
Founded
2025 2003 older
Headquarters
Uppsala, Sweden Yokohama, Japan
Employees
21 58 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology
Funding Stage
Series A Not tracked yet
Total Funding
$11.53M $1.99M
Funding Rounds
6 6
Services
iPSC-derived Models, High-content Phenomic Analysis, Custom Studies and Analytics, Automated Experimentation, Predictive Modeling End-to-End Solutions for Cell Therapy, Stem Cell and Gene Editing Services, Diagnostic Development Support, Preclinical and Clinical Drug Development Support, Biospecimen and Molecular Services
Target Customers
Biopharma Companies, Pharmaceutical Corporations, Research Institutions Cell Therapy Developers, Stem Cell Researchers, Diagnostic Developers, Preclinical Drug Developers, Clinical Drug Developers
Taxonomy
IPSC-derived Human ModelsHigh-throughput ImagingAI-powered PhenomicsDrug DiscoverySafety TestingDisease Modeling +8 Stem Cell ResearchPre-Clinical Drug DevelopmentHuman Tissue AccessHuman Tissue TestingStem Cell Culture MediaIPSC Reprogramming Technologies +9
Website
pixl.bio reprocell.com
pixlbio logo

About pixlbio

pixlbio, born from the merger of DefiniGEN and Phenaros, is pioneering the field of predictive biology by merging iPSC-derived human models with cutting-edge technologies such as high-throughput imaging and AI-powered phenomics. They are setting new standards in drug discovery and safety by capturin...

REPROCELL logo

About REPROCELL

REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes in comprehensive support for stem cell research and pre-clinical drug development. Its unique offer...

Also comparing in this category

Comparing more than these two?

Get pixlbio, REPROCELL and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does pixlbio compare?

A PDF of pixlbio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

pixlbio was founded in 2025, based in Uppsala, Sweden, with 21 employees. pixlbio, born from the merger of DefiniGEN and Phenaros, is pioneering the field of predictive biology by merging iPSC-derived human models with cutting-edge technologies such as high-throughput imagi. REPROCELL was founded in 2003, based in Yokohama, Japan, with 58 employees. REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes.
pixlbio has raised $11.53M and REPROCELL $1.99M. Latest stage: pixlbio Series A.
Both work in Biotechnology and list regenerative medicine among their focus areas.

Compare pixlbio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at pixlbio on 25 Mar 2026, and REPROCELL on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout